| Style | Citing Format |
|---|---|
| MLA | Alizadehasl A, et al.. "Trastuzumab and Ecg Changes Dilemma." International Journal of Hematology-Oncology and Stem Cell Research, vol. 17, no. 2, 2023, pp. 63-64. |
| APA | Alizadehasl A, Mohseni M, Bezanjani FN, Maleki M, Roudini K (2023). Trastuzumab and Ecg Changes Dilemma. International Journal of Hematology-Oncology and Stem Cell Research, 17(2), 63-64. |
| Chicago | Alizadehasl A, Mohseni M, Bezanjani FN, Maleki M, Roudini K. "Trastuzumab and Ecg Changes Dilemma." International Journal of Hematology-Oncology and Stem Cell Research 17, no. 2 (2023): 63-64. |
| Harvard | Alizadehasl A et al. (2023) 'Trastuzumab and Ecg Changes Dilemma', International Journal of Hematology-Oncology and Stem Cell Research, 17(2), pp. 63-64. |
| Vancouver | Alizadehasl A, Mohseni M, Bezanjani FN, Maleki M, Roudini K. Trastuzumab and Ecg Changes Dilemma. International Journal of Hematology-Oncology and Stem Cell Research. 2023;17(2):63-64. |
| BibTex | @article{ author = {Alizadehasl A and Mohseni M and Bezanjani FN and Maleki M and Roudini K}, title = {Trastuzumab and Ecg Changes Dilemma}, journal = {International Journal of Hematology-Oncology and Stem Cell Research}, volume = {17}, number = {2}, pages = {63-64}, year = {2023} } |
| RIS | TY - JOUR AU - Alizadehasl A AU - Mohseni M AU - Bezanjani FN AU - Maleki M AU - Roudini K TI - Trastuzumab and Ecg Changes Dilemma JO - International Journal of Hematology-Oncology and Stem Cell Research VL - 17 IS - 2 SP - 63 EP - 64 PY - 2023 ER - |